Showing results (691-700 of 825) with videos related to

Sort By:
Pageof 83
Journal of Lipid Research|August 25, 2018
Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAFVyala Hanumanthareddy Chaithra, Shancy Petsel Jacob, Chikkamenahalli Lakshminarayana Lakshmikanth, et al.
Journal of the Chinese Medical Association : JCMA|March 29, 2023
Immunoprofile of adenosquamous carcinoma in gastric cancerCheng-Han Wu, Cheng-Lun Lai, Chieh-Lin Jerry Teng, et al.
Plos One|June 11, 2016
Axin-1 Regulates Meiotic Spindle Organization in Mouse OocytesXiao-Qin He, Yue-Qiang Song, Rui Liu, et al.
Scientific Reports|June 17, 2017
Hydrogen gas protects IP3Rs by reducing disulfide bridges in human keratinocytes under oxidative stressChing-Ying Wu, Wen-Li Hsu, Ming-Hsien Tsai, et al.
JCO Oncology Practice|May 6, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung CancerPo-Huang Chen, Hong-Jie Jhou, Wei-Cheng Chang, et al.
Cancer Letters|December 13, 2016
VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesisChun-Wun Lu, Yi-Hsuan Lo, Chu-Huang Chen, et al.
Journal of Medical Systems|March 31, 2012
A physician order category-based clinical guideline comparison systemHwan-Jeu Yu, Chia-Ping Shen, Sarangerel Dorjgochoo, et al.
European Journal of Medicinal Chemistry|March 4, 2014
Design and synthesis of potent antitumor water-soluble phenyl N-mustard-benzenealkylamide conjugates via a bioisostere approachSatishkumar D Tala, Tai-Hsin Ou, Yi-Wen Lin, et al.
Neoplasia (New York, N.Y.)|November 28, 2022
A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancerShin-Yi Chung, Yu-Chan Chang, Dennis Shin-Shian Hsu, et al.
Journal of Medicinal Chemistry|January 31, 2013
Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibitionRavi Chaniyara, Satishkumar Tala, Chi-Wei Chen, et al.
Pageof 83